Drug Type Prophylactic vaccine, mRNA vaccine, Liposomal Drug |
Synonyms- |
Target |
Action agonists |
Mechanism TLR9 agonists(Toll like receptor 9 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hereditary Nonpolyposis Colorectal Cancer | Preclinical | United States | 28 Apr 2025 | |
Hereditary Nonpolyposis Colorectal Cancer | Preclinical | United States | 28 Apr 2025 |